UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042969
Receipt number R000049054
Scientific Title Study on the change of gastric emptying ability by vonoprazan
Date of disclosure of the study information 2021/01/12
Last modified on 2021/06/23 20:22:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the change of gastric emptying ability by vonoprazan
Study on changes in gastric emptying ability due to suppression of acid secretion

Acronym

Study on the change of gastric emptying ability by vonoprazan

Scientific Title

Study on the change of gastric emptying ability by vonoprazan

Scientific Title:Acronym

Study on the change of gastric emptying ability by vonoprazan

Region

Japan


Condition

Condition

functional gastrointestinal disorder

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine how vonoprazan treatment alters gastric emptying capacity in healthy subjects.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

gastric emptying breath test

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

gastric emptying breath test

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

Asymptomatic adults aged 20 to 75 years who participated in UMIN000039199.

Key exclusion criteria

Those who have symptoms of gastric acid reflux or gastric motility insufficiency. Patients with a history of gastrectomy. Patients with active malignancy. Patients with serious complications (heart failure, renal failure, liver failure, respiratory failure, intestinal obstruction) that make it difficult to perform the test. Patients with active gastric ulcer. Patients on dialysis. Pregnant or nursing mothers. Patients with swallowing dysfunction. Those who are allergic to bonoprazan. Patients who cannot express their own will due to dementia or impaired consciousness. Those who are unable to give their consent. Those who are judged as unsuitable as test subjects by the principal investigator (sub-investigator).

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Kazuhide
Middle name
Last name Higuchi

Organization

Osaka Medical College

Division name

Second Department of Internal Medicine

Zip code

569-8686

Address

2-7, Daigaku-machi, Takatsuki-City, Osaka

TEL

072-683-1221

Email

higuchi@osaka-med.ac.jp


Public contact

Name of contact person

1st name Kazuhiro
Middle name
Last name Ota

Organization

Osaka Medical College

Division name

Second department of internal medicine

Zip code

569-8686

Address

2-7, Daigaku-machi, Takatsuki-City, Osaka

TEL

072-683-1221

Homepage URL


Email

in2112@osaka-med.ac.jp


Sponsor or person

Institute

Second Department of Internal Medicine, Osaka Medical College

Institute

Department

Personal name



Funding Source

Organization

Second Department of Internal Medicine, Osaka Medical College

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Medical College

Address

2-7, Daigaku-Machi, Takatsuki-City, Osaka

Tel

072-683-1221

Email

omc_rinsyou@osaka-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

10

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 01 Month 12 Day

Date of IRB

2021 Year 01 Month 15 Day

Anticipated trial start date

2021 Year 01 Month 12 Day

Last follow-up date

2021 Year 02 Month 11 Day

Date of closure to data entry

2021 Year 03 Month 24 Day

Date trial data considered complete

2021 Year 03 Month 24 Day

Date analysis concluded

2021 Year 03 Month 24 Day


Other

Other related information



Management information

Registered date

2021 Year 01 Month 11 Day

Last modified on

2021 Year 06 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049054


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name